Pharmaron
300759.SZPharmaron Beijing Co., Ltd. Price (300759.SZ)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
1,775,257,234
(0.0544)%Revenue and Profitability
| Year | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 790,440,047 | 1,128,037,558 | 1,634,238,680 | 2,294,118,066 | 2,908,123,033 | 3,757,160,086 | 5,133,596,758 | 7,443,769,724 | 10,266,288,179 | 11,537,996,314 |
| Net Income | 20,995,240 | 73,846,442 | 176,911,924 | 230,857,087 | 339,224,479 | 547,191,486 | 1,172,382,387 | 1,661,028,567 | 1,374,604,224 | 1,601,096,033 |
| FCF USD | -69,804,811 | -41,383,792 | -819,721,583 | -382,451,214 | 96,272,715 | 183,980,375 | 332,771,602 | -34,777,738 | -807,044,736 | -111,781,877 |
| OCF USD | 12,134,600 | 216,939,062 | 235,767,733 | 552,215,324 | 737,258,351 | 938,586,321 | 1,648,609,957 | 2,058,043,830 | 2,142,816,416 | 2,753,538,934 |
Financial Health - DEBT
| Year | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| YTPD | 0.00 | 0.36 | 2.34 | 4.54 | 3.01 | 1.27 | 0.51 | 2.91 | 3.86 | 5.55 |
| D/E | 0.73 | 1.25 | 0.35 | 0.65 | 0.61 | 0.13 | 0.12 | 0.52 | 0.58 | 0.75 |
| CA/CL | 0.59 | 0.45 | 1.66 | 1.15 | 1.02 | 4.68 | 2.80 | 2.90 | 1.67 | 2.98 |
| TA/TL | 1.38 | 1.17 | 2.69 | 2.05 | 2.03 | 4.74 | 4.00 | 2.27 | 2.12 | 2.00 |
| Total Debt | 189,258,018 | 211,191,903 | 624,741,848 | 1,301,208,298 | 1,415,941,337 | 1,037,991,660 | 1,051,489,202 | 5,285,116,051 | 6,116,522,231 | 9,361,933,739 |
Management Performance
| Year | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROIC | 3.55% | 16.22% | 6.23% | 6.59% | 8.58% | 5.97% | 11.17% | 10.25% | 7.95% | 6.80% |
| ROE | 8.13% | 43.84% | 10.03% | 11.56% | 14.57% | 7.05% | 13.22% | 16.40% | 13.03% | 12.75% |
| ROA | 0.00% | 6.29% | 6.31% | 5.79% | 7.33% | 5.34% | 9.63% | 8.81% | 6.60% | 5.97% |
| NM % | 2.66% | 6.55% | 10.83% | 10.06% | 11.66% | 14.56% | 22.84% | 22.31% | 13.39% | 13.88% |
| FCF / R% | 0.00% | -3.67% | -50.16% | -16.67% | 3.31% | 4.90% | 6.48% | -0.47% | -7.86% | -0.97% |
| FCF / NI% | -332.48% | -56.04% | -463.35% | -168.46% | 28.40% | 34.67% | 29.01% | -2.15% | -59.69% | -7.07% |
| Operating Margin (OM) | 0.00 | -0.08 | 0.02 | 0.11 | 0.19 | 0.26 | 0.38 | 0.43 | 0.40 | 0.45 |
Per Share
| Year | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS | 0.04 | 0.15 | 0.23 | 0.26 | 0.38 | 0.37 | 0.66 | 0.93 | 0.78 | 0.90 |
| SPS | 1.56 | 2.23 | 2.16 | 2.58 | 3.28 | 2.53 | 2.89 | 4.18 | 5.79 | 6.50 |
| OCPS | 0.02 | 0.43 | 0.31 | 0.62 | 0.83 | 0.63 | 0.93 | 1.16 | 1.21 | 1.55 |
| FCPS | -0.14 | -0.08 | -1.08 | -0.43 | 0.11 | 0.12 | 0.19 | -0.02 | -0.46 | -0.06 |
| BVPS | 0.51 | 0.33 | 2.33 | 2.26 | 2.64 | 5.27 | 5.02 | 5.78 | 6.11 | 7.46 |
Per Share - CAGR
| Year | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| CAGR-EPS | 0.04 | 0.15 | 0.23 | 0.26 | 0.38 | 0.37 | 0.66 | 0.93 | 0.78 | 0.90 |
| CAGR-SPS | 1.56 | 2.23 | 2.16 | 2.58 | 3.28 | 2.53 | 2.89 | 4.18 | 5.79 | 6.50 |
| CAGR-OCPS | 0.02 | 0.43 | 0.31 | 0.62 | 0.83 | 0.63 | 0.93 | 1.16 | 1.21 | 1.55 |
| CAGR-FCPS | -0.14 | -0.08 | -1.08 | -0.43 | 0.11 | 0.12 | 0.19 | -0.02 | -0.46 | -0.06 |
| CAGR-BVPS | 0.51 | 0.33 | 2.33 | 2.26 | 2.64 | 5.27 | 5.02 | 5.78 | 6.11 | 7.46 |